Graham Capital Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,676
Closed -$217K 1443
2025
Q2
$217K Buy
+1,676
New +$243K ﹤0.01% 1101
2025
Q1
Sell
-1,478
Closed -$274K 1391
2024
Q4
$274K Buy
+1,478
New +$287K ﹤0.01% 970
2023
Q4
Sell
-1,256
Closed -$249K 1149
2023
Q3
$249K Buy
+1,256
New +$317K 0.01% 785
2023
Q2
Sell
-6,814
Closed -$1.59M 1128
2023
Q1
$1.59M Buy
6,814
+10
+0.1% +$2.53K 0.05% 327
2022
Q4
$1.71M Buy
+6,804
New +$1.45M 0.05% 339
2022
Q3
Sell
-2,527
Closed -$461K 1169
2022
Q2
$461K Buy
+2,527
New +$504K 0.02% 696

Other funds holding INSP

Graham Capital Management's INSP Position: Q3 2025 in Review

Graham Capital Management sold out of Inspire Medical Systems (INSP) in Q3 2025, closing a stake of 1,676 shares — an estimated $217K sold.

Graham Capital Management first reported a position in INSP in Q2 2022 and held it in 6 quarters. The position peaked at $1.71M in Q4 2022. 325 funds tracked by Wall St. Rank hold INSP as of Q3 2025.

  • Graham Capital Management reported no remaining Inspire Medical Systems position as of Q3 2025 after selling out during the quarter.
  • Graham Capital Management sold 1,676 Inspire Medical Systems shares in Q3 2025, an estimated $217K.
  • Graham Capital Management first reported a position in Inspire Medical Systems in Q2 2022 and held it in 6 quarters.
  • Graham Capital Management's Inspire Medical Systems position peaked at $1.71M in Q4 2022.
  • 325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2025.

Based on Graham Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.